Ericifolin: A novel antitumor compound from allspice that silences androgen receptor in prostate cancer

Carcinogenesis

Volumn 34, Issue 8, 2013, Pages 1822-1832

  Shamaladevi, Nagarajarao ^a,b   Lyn, Dominic A ^a   Shaaban, Khaled A ^c   Zhang, Lei ^a   Villate, Susana ^a   Rohr, Jürgen ^c   Lokeshwar, Bal L ^a,b,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c University of Kentucky   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; CASPASE; ERICIFOLIN; EUGENOL 5 O BETA(6' GALLOYLGLUCOPYRANOSIDE); MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLSPICE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CASTRATION RESISTANT PROSTATE CANCER; CELL DEATH; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG ISOLATION; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84881508927     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt123     Document Type: Article

References (49)

1. Ross, J.A. et al. (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 22, 19-34.
2. Aggarwal, B.B. et al. (2009) Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med., 234, 825-849.
3. Marzouk, M.S. et al. (2007) Anticancer and antioxidant tannins from Pimenta dioica leaves. Z. Naturforsch. C., 62, 526-536.
4. Suárez, A. et al. (1997) Cardiovascular effects of ethanolic and aqueous extracts of Pimenta dioica in Sprague-Dawley rats. J. Ethnopharmacol., 55, 107-111.
5. Suárez, A. et al. (2000) Hypotensive action of an aqueous extract of Pimenta dioica (Myrtaceae) in rats. Rev. Biol. Trop., 48, 53-58.
6. Nakatani, N. (2000) Phenolic antioxidants from herbs and spices. Biofactors, 13, 141-146.
7. Kikuzaki, H. et al. (2000) Galloylglucosides from berries of Pimenta dioica. J. Nat. Prod., 63, 749-752.
8. Tanaka, T. et al. (1993) Eugenin and galloyl pedunculagin were isolated from Platycarya strobilaceae. Chem. Pharm. Bull., 41, 1708-1716.
9. Siegel, R. et al. (2012) Cancer statistics, 2012. CA. Cancer J. Clin., 62, 10-29.
10. Debes, J.D. et al. (2004) Mechanisms of androgen-refractory prostate cancer. N. Engl. J. Med., 351, 1488-1490.
11. Nelson, W.G. et al. (2003) Prostate cancer. N. Engl. J. Med., 349, 366-381.
12. Chen, C.D. et al. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat. Med., 10, 33-39.
13. Chen, Y. et al. (2008) Targeting the androgen receptor pathway in prostate cancer. Curr. Opin. Pharmacol., 8, 440-448.
14. Clegg, N.J. et al. (2012) ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Res., 72, 1495-1503.
15. Scher, H.I. et al. (2005) Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J. Clin. Oncol., 23, 8253-8261.
16. Lokeshwar, B.L. et al. (2002) Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int. J. Cancer, 98, 297-309.
17. Dandekar, D.S. et al. (2004) Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs. Clin. Cancer Res., 10, 8037-8047.
18. Shamaladevi, N. et al. (2009) CXC receptor-1 silencing inhibits androgenindependent prostate cancer. Cancer Res., 69, 8265-8274.
19. Wang, L.G. et al. (2004) Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene, 23, 5175-5184.
20. Perez-Stable, C.M. et al. (2000) A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol. Cell. Endocrinol., 167, 43-53.
21. Singh, R.K. et al. (2009) Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs. Mol. Cancer, 8, 57.
22. Dupont, W.D. et al. (1990) Power and sample size calculations. A review and computer program. Control. Clin. Trials, 11, 116-128.
23. Singleton, D.L. et al. (1965) Colorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. Am. J. Enol. Viticult., 16, 144-158.
24. König, M. et al. (1994) Ellagitannins and complex tannins from Quercus petraea bark. J. Nat. Prod., 57, 1411-1415.
25. Van Berkel, G.J. et al. (2007) Thin-layer chromatography/desorption electrospray ionization mass spectrometry: investigation of goldenseal alkaloids. Anal. Chem., 79, 2778-2789.
26. Nieman, R.H. et al. (1963) Spectrophotometric estimation of nucleic acid of plant leaves. Plant Physiol., 38, 31-35.
27. Strumeyer, D.H. et al. (1975) Condensed tannins in grain sorghum: isolation, fractionation, and characterization. J. Agric. Food Chem., 23, 909-914.
28. He, S. et al. (2007) Isolation and purification of antioxidative isomeric polyphenols from the roots for parthenocissus laetevirens by counter-current chromatography. J. Chromatogr A, 1151, 175-179.
29. Lokeshwar, B.L. et al. (1995) Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy. Anticancer Res., 15, 93-98.
30. Kim, R. (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 103, 1551-1560.
31. Lokeshwar, B.L. et al. (2001) Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3). Curr. Med. Chem., 8, 271-279.
32. Cory, S. et al. (2002) The Bcl2 family: regulators of the cellular life-ordeath switch. Nat. Rev. Cancer, 2, 647-656.
33. Li, J. et al. (2008) Caspases in apoptosis and beyond. Oncogene, 27, 6194-6206.
34. Joza, N. et al. (2009) AIF: not just an apoptosis-inducing factor. Ann. N. Y. Acad. Sci., 1171, 2-11.
35. Lee, J.H. et al. (2010) EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosisinducing factor and endonuclease G. Cancer Lett., 290, 68-75.
36. Tanida, I. et al. (2008) LC3 and autophagy. In Deretic, V (ed.) Methods in Molecular Biology: Autophagosome and Phagosome. Humana Press, Totowa, New Jersey, pp.77-88.
37. Lee, D.H. et al. (1996) Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem., 271, 27280-27284.
38. Araki, S. et al. (2007) Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res., 67, 6854-6862.
39. Koochekpour, S. et al. (2004) Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA. Prostate, 60, 141-152.
40. Dai, J.L. et al. (1996) Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids, 61, 531-539.
41. Adhami, V.M. et al. (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res., 13, 1611-1619.
42. Hussein, S.A. et al. (2007) Ericifolin: an eugenol 5-O-galloylglucoside and other phenolics from Melaleuca ericifolia. Phytochemistry, 68, 1464-1470.
43. Burnstein, K.L. (2005) Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. J. Cell. Biochem., 95, 657-669.
44. Zhau, H.Y. et al. (1996) Androgen-repressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. U. S. A., 93, 15152-15157.
45. Singh, M. et al. (2011) Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol. Res., 19, 245-257.
46. Rodríguez-Ramiro, I. et al. (2011) Comparative effects of dietary flavanols on antioxidant defences and their response to oxidant-induced stress on Caco2 cells. Eur. J. Nutr., 50, 313-322.
47. Tanida, I. et al. (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy, 1, 84-91.
48. Chu, C.P. et al. (2009) Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett., 275, 86-92.
49. Bosetti, C. et al. (2005) Flavonoids and breast cancer risk in Italy. Cancer Epidemiol. Biomarkers Prev., 14, 805-808.